Dasatinib induces significant hematologic and cytogenetic esponses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase / Guilhot F; Apperley J; Kim DW; Bullorsky EO; Baccarani M; Roboz GJ; Amadori S; de Souza CA; Lipton JH; Hochhaus A; Heim D; Larson RA; Branford S; Muller MC; Agarwal P; Gollerkeri A; Talpaz M.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 109:(2007), pp. 4143-4150. [10.1182/blood-2006-09-046839]
Dasatinib induces significant hematologic and cytogenetic esponses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.
BACCARANI, MICHELE;
2007
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
